Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1998
10/22/1998WO1998046245A1 Method and composition for treating sleep apnea
10/22/1998WO1998046241A1 A combination therapy for hiv infections
10/22/1998WO1998046238A1 Biflavinoids and derivatives thereof as antiviral agents, alone or in combination with at least one known antiviral agent
10/22/1998WO1998046224A1 Compositions and method for treating bladder dysfunction
10/22/1998WO1998046222A1 Pharmaceutical compositions for immunosuppression, anticancer and antiviral treatment
10/22/1998WO1998046210A1 Method and composition for targeted delivery of compounds
10/22/1998WO1998046209A1 Use of microparticles having a protein and an antibody adsorbed thereon for preparing a pharmaceutical composition for intranasal administration
10/22/1998WO1998046208A1 Hair follicle dna delivery system
10/22/1998WO1998046083A1 Use of lentiviral vectors for antigen presentation in dendritic cells
10/22/1998WO1998046082A1 Cell-coated supports
10/22/1998WO1998046077A1 A method for treating papillomavirus infections
10/22/1998WO1998036068A3 Human p24 vesicle proteins
10/22/1998WO1998035028A3 An oncolytic/immunogenic complementary-adenoviral vector system
10/22/1998WO1998034949A3 Monocyclic compounds with four bifunctional residues having nk-2 antagonist action
10/22/1998WO1998031815A3 Subunits of nadh dehydrogenase
10/22/1998WO1998031793A3 Immunomodulating properties, amino acid and nucleotide sequence of colostrum derived growth factor
10/22/1998WO1998002190A3 Cationic amphiphile/dna complexes
10/22/1998DE19749973C1 New T4 lysozyme polypeptide compounds
10/22/1998DE19745792C1 Isolation of wound healing regulatory factors
10/22/1998DE19716167A1 Purification of cyclosporin A and related cyclosporins from crude extract
10/22/1998DE19716154A1 Stabile pharmazeutische Darreichungsform für Peptide, Proteine und Nukleinsäuren The stable pharmaceutical dosage form of peptides, proteins and nucleic acids
10/22/1998DE19716098A1 Fibroblasten mit einem Fremdgen enthaltende Zusammensetzung zur Behandlung von Wunden Fibroblasts with a foreign gene containing composition for the treatment of wounds
10/22/1998CA2781623A1 Novel protein binding to osteoclastogenesis inhibitory factor and process for producing the same
10/22/1998CA2706609A1 Osteoprotegerin binding proteins and receptors
10/22/1998CA2293311A1 Synergistic method for treating cancer
10/22/1998CA2291705A1 Receptors for tgf-.beta.-related neurotrophic factors
10/22/1998CA2289476A1 Modified tnf.alpha. molecules, dna encoding such modified tnf.alpha. molecules and vaccines comprising such modified tnf.alpha. molecules and dna
10/22/1998CA2288968A1 Permucous preparation
10/22/1998CA2287779A1 Human tumor-associated kazal inhibitor
10/22/1998CA2287526A1 Novel dlg family molecule, polynucleotide encoding the same, antibody against the same, and method for detecting dlg gene
10/22/1998CA2287518A1 A novel th2-specific gene
10/22/1998CA2287450A1 A novel human g-protein coupled receptor
10/22/1998CA2287085A1 Tumor necrosis factor receptor related proteins tango-63d and tango-63e
10/22/1998CA2286934A1 Novel polypeptides within the growth factor superfamily
10/22/1998CA2286877A1 Peptide antiestrogen compositions and methods for treating breast cancer
10/22/1998CA2286859A1 Herpes simplex virus us3 and icp4 as inhibitors of apoptosis
10/22/1998CA2286819A1 Use of lentiviral vectors for antigen presentation in dendritic cells
10/22/1998CA2286798A1 Alpha-o-linked glycoconjugates with clustered(2,6)-st epitopes, methods of preparation and uses thereof
10/22/1998CA2286791A1 Use of cartilage oligomeric matrix protein for the treatment of rheumatoid arthritis
10/22/1998CA2286580A1 Adenoviral vectors comprising a modified e4 region but retaining e4orf3
10/22/1998CA2286484A1 .beta.-amyloid peptide-binding proteins and polynucleotides encoding the same
10/22/1998CA2286478A1 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
10/22/1998CA2286477A1 Composition and method for inducing an immune response against tumour-related antigens
10/22/1998CA2286351A1 Extracellular/epidermal growth factor like protein
10/22/1998CA2286332A1 Inhibitors for urokinase receptor
10/22/1998CA2286290A1 Secreted proteins and polynucleotides encoding them
10/22/1998CA2286263A1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids
10/22/1998CA2286137A1 Ngf for the prevention of demyelination in the nervous system
10/22/1998CA2285968A1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids
10/22/1998CA2285940A1 Use of chondroitinase in the manufacture of a medicament in the treatment and prevention of mucoid secretions
10/22/1998CA2285705A1 Selective factor xa inhibitors
10/22/1998CA2285685A1 Selective factor xa inhibitors
10/22/1998CA2285659A1 Selective factor xa inhibitors
10/22/1998CA2285572A1 A method for treating papillomavirus infections
10/22/1998CA2284832A1 Proteins having lecithin-cholesterol acyltransferase-like activity, their production and use
10/22/1998CA2284726A1 Antagonistic anti-avb3 integrin antibodies
10/22/1998CA2284127A1 Flt3 ligand chimeric proteins
10/22/1998CA2283511A1 Teicoplanin derivatives
10/22/1998CA2283435A1 Deacylation process and product
10/22/1998CA2234399A1 Cdna clone hmtmf81 that encodes a novel human 7-transmembrane receptor
10/22/1998CA2231740A1 Cdna clone hmtmf81 that encodes a novel human 7-transmembrane receptor
10/22/1998CA2229428A1 3-dehydroquinate synthase (arob)
10/21/1998EP0872557A1 Neutrophil chemotactic lymphokine, and drug and kit for the diagnosis of drug hypersensitive granulocytopenia containing the same
10/21/1998EP0872552A1 A gene delivery vehicle expressing the apoptosis-inducing proteins VP2 and/or Apoptin
10/21/1998EP0872550A2 cDNA clone HACCH94 that encodes a human 7-transmembrane receptor
10/21/1998EP0872488A1 MONOCLONAL ANTIBODY REACTING SPECIFICALLY WITH Fas LIGAND AND PROCESS FOR PRODUCING THE SAME
10/21/1998EP0872486A1 Eimeria proteins as vaccines
10/21/1998EP0872245A1 Methods for treating vascular disorders with activated Protein C
10/21/1998EP0871883A1 Compounds and methods related to parathyroid hormone-like protein
10/21/1998EP0871763A1 Method for preparation of type ii collagen
10/21/1998EP0871748A2 Delivery of biologically active polypeptides
10/21/1998EP0871745A1 Aspergillus arabinofuranosidase
10/21/1998EP0871733A2 Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease
10/21/1998EP0871732A1 Method of treating sepsis
10/21/1998EP0871730A1 Combination pdgf, kgf, igf and igfbp for wound healing
10/21/1998EP0871728A2 Targets for breast cancer diagnosis and treatment
10/21/1998EP0871725A2 P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
10/21/1998EP0871724A1 Expression of processed recombinant lactoferrin and lactoferrin polypeptide fragments from a fusion product in aspergillus
10/21/1998EP0871723A1 Somatic gene therapy to cells associated with fluid spaces
10/21/1998EP0871721A1 A protein-lipid conjugate, consisting of heparin binding protein (hbp) and a ceramide analogue, and its pharmaceutical use in treatment of conditions involving stress injury to cells
10/21/1998EP0871713A2 The use of lecithin-cholesterol acyltransferase (lcat) in the treatment of atherosclerosis
10/21/1998EP0871710A1 Recombinant c-proteinase and processes, methods and uses thereof
10/21/1998EP0871705A1 Human ccn-like growth factor
10/21/1998EP0871703A1 Dna encoding glutamate gated chloride channels
10/21/1998EP0871702A1 Cytokine designated lerk-7
10/21/1998EP0871673A1 Bispecific antibodies in which the binding capability is reversibly inhibited by a photocleavable moiety
10/21/1998EP0871672A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
10/21/1998EP0871670A2 INHIBITORS OF MAdCAM-1-MEDIATED INTERACTIONS AND METHODS OF USE THEREFOR
10/21/1998EP0871669A1 Human somatostatin-like receptor
10/21/1998EP0871667A1 G-protein coupled receptor
10/21/1998EP0871666A1 Receptor-selective somatostatin analogs
10/21/1998EP0871665A1 Insulin derivatives
10/21/1998EP0871664A1 Novel chemokine for mobilizing stem cells
10/21/1998EP0871663A2 New form of amphiregulin, methods for producing and using the same and compositions comprising the same
10/21/1998EP0871662A1 Product derived from milk substantially free of beta casein from non-human mammals and relative use
10/21/1998EP0871661A1 Novel protein domain which binds tyrosine phosphorylated proteins
10/21/1998EP0871660A1 A 12-kda protein derived from m. tuberculosis useful for treatment of autoimmune diseases
10/21/1998EP0871657A1 Methods for treatment and prevention of diabetes
10/21/1998EP0871656A1 Novel dolastatin derivatives, their preparation and use
10/21/1998EP0871655A2 Pcna binding substance